SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037601
Filing Date
2023-08-03
Accepted
2023-08-03 07:56:00
Documents
47
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-20230630.htm   iXBRL 10-Q 1915060
2 EX-4.1 wve-ex4_1.htm EX-4.1 252755
3 EX-31.1 wve-ex31_1.htm EX-31.1 19958
4 EX-31.2 wve-ex31_2.htm EX-31.2 20353
5 EX-32 wve-ex32.htm EX-32 14871
6 GRAPHIC img56420585_0.jpg GRAPHIC 98426
7 GRAPHIC img56420585_1.jpg GRAPHIC 141062
  Complete submission text file 0000950170-23-037601.txt   5561896

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT wve-20230630_def.xml EX-101.DEF 116029
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wve-20230630.xsd EX-101.SCH 30343
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wve-20230630_pre.xml EX-101.PRE 193197
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wve-20230630_lab.xml EX-101.LAB 278950
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT wve-20230630_cal.xml EX-101.CAL 32884
41 EXTRACTED XBRL INSTANCE DOCUMENT wve-20230630_htm.xml XML 386928
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 231138136
SIC: 2834 Pharmaceutical Preparations